Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2002
06/12/2002EP1213297A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same
06/12/2002EP1213032A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/12/2002EP1212941A2 Modulating ramp activity
06/12/2002EP1212620A1 Essential genes and assays relating thereto
06/12/2002EP1212615A2 Methods of screening for macrophage development modulators
06/12/2002EP1212446A2 Viral replicons and viruses dependent on inducing agents
06/12/2002EP1212444A1 Dna construct and its use
06/12/2002EP1212443A2 Targeted gene removal
06/12/2002EP1212442A2 Enhanced plant cell transformation by addition of host genes involved in t-dna integration
06/12/2002EP1212441A2 Plant regulatory sequences for control of gene expression
06/12/2002EP1212440A2 Plants having reduced activity in two or more starch-modifying enzymes
06/12/2002EP1212439A1 Plants having altered amino acid contents and method for the production thereof
06/12/2002EP1212438A1 Flax seed specific promoters
06/12/2002EP1212436A2 Protein phosphatase and kinase proteins
06/12/2002EP1212433A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders
06/12/2002EP1212431A2 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans
06/12/2002EP1212422A2 Human ctla-4 antibodies and their uses
06/12/2002EP1212421A1 Gas1 polypeptides
06/12/2002EP1212420A1 Conditional immortalisation of cells
06/12/2002EP1212419A2 Polycyclic aromatic hydrocarbon induced molecules
06/12/2002EP1212418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF
06/12/2002EP1212417A2 Interleukin-1-receptor associated kinase-3 (irak3)
06/12/2002EP1212416A2 Nucleic acid based modulators of gene expression
06/12/2002EP1212415A1 Pgrp-l polynucleotides, polypeptides, and antibodies
06/12/2002EP1212413A1 A transmembrane trap for isolating membrane bound proteins
06/12/2002EP1212412A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis
06/12/2002EP1212411A2 Methods and compositions for the construction and use of fusion libraries
06/12/2002EP1212410A2 Dna encoding the human serine protease eos
06/12/2002EP1212407A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies
06/12/2002EP1212405A2 Use of cytokines, cells, and mitogens to inhibit graft versus host disease
06/12/2002EP1212404A2 Isolation of muscle-derived stem cells and uses therefore
06/12/2002EP1212403A1 Method for treatment of beta-hemoglobinopathies
06/12/2002EP1212362A2 Card proteins involved in cell death regulation
06/12/2002EP1212359A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein
06/12/2002EP1212355A2 Pharmaceutical compositions and methods of using secreted frizzled related protein
06/12/2002EP1212353A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
06/12/2002EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies
06/12/2002EP1212343A1 52 human secreted proteins
06/12/2002EP1212342A2 18 human secreted proteins
06/12/2002EP1212341A1 Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase
06/12/2002EP1212340A1 29 human cancer associated proteins
06/12/2002EP1212100A2 Delivery system for antidandruff agent
06/12/2002EP1212082A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
06/12/2002EP1212076A2 Stimulation of sperm function
06/12/2002EP1211933A1 Pa28 modified transgenic mice
06/12/2002EP1211931A1 A knockout mouse for the tumor suppressor gene anx7
06/12/2002EP1084227A4 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
06/12/2002EP1018884A4 METHOD OF TREATING BLINDNESS WITH hNT HUMAN NEURONAL CELLS
06/12/2002EP0989855A4 Osteoarthritis cartilage regeneration using human mesenchymal stem cells
06/12/2002EP0983364B1 Dna polymerases having improved labeled nucleotide incorporation properties
06/12/2002EP0914416B1 Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
06/12/2002EP0832212A4 Intergenic regions of banana bunchy top virus
06/12/2002EP0822941B1 Monoclonal antibodies against hiv-1 and vaccines made thereof
06/12/2002EP0817833B1 Filter device
06/12/2002EP0802800B1 Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules
06/12/2002EP0722452B1 Nf-at polypeptides and polynucleotides
06/12/2002EP0662124B1 High speed flow cytometric separation of viable mammalian cells
06/12/2002EP0574395B1 Cytokine immunoconjugates
06/12/2002EP0433372B1 Oral immunization by transgenic plants
06/12/2002CN1353764A Method for selecting improved vectors
06/12/2002CN1353763A Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
06/12/2002CN1353760A Nucleic acid sequences to proteins involved in isoprenoid synthesis
06/12/2002CN1353756A Compositions and method for the modification of gene expression
06/12/2002CN1353617A Treatment of infertility
06/12/2002CN1353575A i(in Vitro) induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
06/12/2002CN1352990A Bio-active substance of antrodia camphorata mycelia, its preparing process and its composition
06/11/2002US6403864 Precursor polypeptide of a plant growth factor, a gene encoding a precursor polypeptide of a plant growth factor and a method for promotion of plant growth
06/11/2002US6403862 Isolated promoter capable of driving transcription in seed-preferred manner which comprises polynucleotide having specified sequence
06/11/2002US6403860 Ku80 homologue and uses thereof
06/11/2002US6403765 Truncated Apaf-1 and methods of use thereof
06/11/2002US6403559 C-kit ligand-based method for expanding peripheral blood cell levels
06/11/2002US6403557 Fibroblast growth factor-13
06/11/2002US6403552 Ob receptor and methods for the diagnosis and treatment of body weight disorders
06/11/2002US6403376 Vitrification; cooling; controlling temperature
06/11/2002US6403375 Establishment of Trichoplusia ni cell lines in serum-free medium for recombinant protein and baculovirus production
06/11/2002US6403374 Long wavelength engineered fluorescent proteins
06/11/2002US6403372 Aspergillus fumigatus profilin
06/11/2002US6403360 Isolated nucleic acids
06/11/2002US6403356 Mutant penicillin G acylases
06/11/2002US6403354 Dna from bacillus; genetic engineering
06/11/2002US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics
06/11/2002US6403348 Controlled electroporation and mass transfer across cell membranes
06/11/2002US6403343 Plant extract
06/11/2002US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering
06/11/2002US6403318 Fatty acid synthase mRNA binding protein
06/11/2002US6403307 Amplification of genomic dna or mrna or complement; analyzing for mutation
06/11/2002US6403304 Human osteoclast-specific and -related DNA sequences
06/11/2002US6403300 Monoclonal antibodies for detection of friend murine leukemia virus
06/11/2002US6403299 Transforming non-leflunomide resistant cell with dna sequence encoding deah box protein that binds atp and nucleic acid; culturing; modulating helicase activity; genetic engineering
06/11/2002US6403124 Storage and maintenance of blood products including red blood cells and platelets
06/11/2002US6403102 Chlamydia antigens and corresponding DNA fragments and uses thereof
06/11/2002US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof
06/11/2002US6403094 Clostridium perfringens vaccines
06/11/2002US6403091 Produced by the hybridoma having atcc accession no. hb 10916.
06/11/2002US6403080 Methods of modulating an immune response to antigen, and cells for use in the method
06/11/2002US6403079 Using polypeptide
06/11/2002CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens
06/11/2002CA2082390C Dna encoding human 5-ht1d receptors and uses thereof
06/11/2002CA1341367C Enhanced production of proteins by cell culture
06/06/2002WO2002044734A1 Method for diagnosing a tumor in a patient determining the concentration of pibf